Hospira Boulder, Inc.

FDA inspection history across 2 sites, 2002 to 2025

11
Form 483s

Every document, by year

  • Form 483

2002: one Form 483; 2007: one Form 483; 2010: one Form 483; 2012: two Form 483s; 2016: one Form 483; 2017: one Form 483; 2018: one Form 483; 2020: one Form 483; 2023: one Form 483; 2025: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2002One Form 483, at McPherson, Kansas.
  2. 2007One Form 483, at McPherson, Kansas.
  3. 2010–12Three Form 483s, at McPherson, Kansas and Mcpherson, Kansas.
  4. 2016–20Four Form 483s, at McPherson, Kansas and Mcpherson, Kansas.
  5. 2016The longest 483 on file: 14 observations over 21 pages at McPherson, Kansas.
  6. 2023–25Two Form 483s, at McPherson, Kansas.

Cited most

Across all Hospira Boulder observations on file

The complete Hospira Boulder file.

All 11 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$817$1,089

25% off buying them one by one

Sites

Documents

11 on file, newest first
DateDocumentPrice
2025-01-17483 Form 483$99
2023-06-30483 Form 483$99
2020-01-17483 Form 483$99
2018-08-08483 Form 483$99
2017-10-27483 Form 483$99
2016-06-08483 Form 483$99
2012-10-24483 Form 483$99
2012-01-04483 Form 483$99
2010-02-03483 Form 483$99
2007-08-30483 Form 483$99
2002-09-12483 Form 483$99

FEI number 1925262 · most recent document Jan 17, 2025

About Hospira Boulder, Inc.

How many FDA Form 483s has Hospira Boulder, Inc. received?

FDA Intel has 11 Form 483s on file for Hospira Boulder, Inc.; the most recent is dated Jan 17, 2025.

When was Hospira Boulder, Inc. last inspected by FDA?

The most recent FDA inspection document on file for Hospira Boulder, Inc. is a Form 483 dated Jan 17, 2025, for the site in McPherson, Kansas.

What did FDA cite at Hospira Boulder, Inc.?

The regulations cited most in the observations on file for Hospira Boulder, Inc. are 21 CFR 211.113 (Control of microbiological contamination), 11 times; 21 CFR 211.192 (Production record review), 9 times; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 5 times.